COVID-19 Vaccine Responses Vary Among Hematological Malignancies

A systematic review and meta-analysis of 44 clinical studies published between January and August 2021, finds an overall reasonable response to COVID-19 vaccinations for patients with underlying hematological malignancies. The authors describe an urgent need for more effective regimens for high-risk patients. The study was made available as a preprint on medRxiv on November 8, 2021, and has not ye
First Look

source https://www.medscape.com/viewarticle/966288?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?